Motilal Oswal lifts Zydus Wellness target to Rs 600, sees 26% revenue CAGR through FY28
Post Q4, Motilal Oswal reiterates Buy on Zydus Wellness, citing core portfolio stability plus RiteBite and Comfort Click acquisitions. Brokerage models 26% consolidated revenue CAGR and 37% Ebitda CAGR over FY26-28E, valuing the stock at 23x FY27 and 18x FY28 EV/Ebitda.
What happened
Motilal Oswal reiterates Buy on Zydus Wellness with Rs 600 target post Q4, citing core stability and growth from RiteBite and Comfort Click acquisitions,
Key facts
- Target Rs 600
- 23x FY27 EV/Ebitda
- 18x FY28 EV/Ebitda
- 11% domestic revenue CAGR
- 20% Ebitda CAGR FY26-28E
- 26% consolidated revenue CAGR
- 37% Ebitda CAGR
Why this matters
RiteBite and Comfort Click are now baseline assumptions in the Street's CAGR model—any further bolt-ons should target adjacencies that defend the 37% Ebitda trajectory rather than dilute it.